High blood pressure: open trials in Netherlands

35 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT06526195
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Trial Treatment · Abbott Medical Devices
Erasmus MC - Thoraxcenter, Rotterdam · UMC Utrecht, Utrecht
Registry updated 2026-11-05
NCT07919405
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
Trial Treatment · Phase 3 · Novo Nordisk A/S
Deventer Ziekenhuis - Interne geneeskunde, Deventer · Albert Schweitzer Zkh, Dordwijk - Nefrologie, Dordrecht · Catharina Zkh Eindhoven - Interne geneeskunde, Eindhoven · Spaarne Gasthuis Haarlem - Interne, Haarlem · Zuyderland ziekenhuis - Interne, Heerlen · Bethesda Diabetes Research Center, Hoogeveen · RadboudUMC - Vasculaire geneeskunde, Nijmegen · UMC Utrecht - Vasculaire geneeskunde, Utrecht
Registry updated 2026-11-05
NCT06452498
Preeclampsia Intervention Netherlands
Trial Treatment · Phase 3 · Amsterdam UMC
Amsterdam UMC, Amsterdam
Registry updated 2026-11-04
NCT05587712
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Universitair Medisch Centrum Groningen, Groningen
Registry updated 2026-11-02
NCT06317805
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Trial Treatment · Phase 4 · AOP Orphan Pharmaceuticals AG
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-10-29
NCT06823115
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Research · Indiana University
Amalia Children's Hospital Radboudumc, Nijmegen
Registry updated 2026-10-28
NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Trial Treatment · Phase 3 · Boehringer Ingelheim
Meander Medisch Centrum, Amersfoort · Stichting OLVG, Amsterdam · Brain Research Center Amsterdam B.V., Amsterdam · Amsterdam UMC Stichting, Amsterdam · Rijnstate Ziekenhuis Stichting, Arnhem · PreCare Trial & Recruitment B.V., Beek Lb · Rode Kruis Ziekenhuis B.V., Beverwijk · Reinier de Graaf Groep, Delft · Catharina Ziekenhuis Stichting, Eindhoven · Máxima Medisch Centrum, Eindhoven · Treant Ziekenhuiszorg Stichting, Emmen · Admiraal De Ruyter Ziekenhuis B.V., Goes · Universitair Medisch Centrum Groningen, Groningen · Tergooiziekenhuizen, Hilversum · Treant Ziekenhuiszorg Stichting, Hoogeveen · Academisch Ziekenhuis Maastricht, Maastricht · Radboud universitair medisch centrum Stichting, Nijmegen · Brain Research Center Den Bosch B.V., 's-Hertogenbosch · Jeroen Bosch Ziekenhuis Stichting, 'S-Hertogenbosch · D & A Research B.V., Sneek · Treant Ziekenhuiszorg Stichting, Stadskanaal · Diakonessenhuis Stichting, Utrecht · Universitair Medisch Centrum Utrecht, Utrecht · Isala Klinieken Stichting, Zwolle · Brain Research Center Zwolle B.V., Zwolle
Registry updated 2026-10-28
NCT07115953
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
Trial Treatment · Medtronic Vascular
Zuyderland Medisch Centrum - Heerlen, Heerlen · Erasmus University Medical Center, Rotterdam
Registry updated 2026-10-16
NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Alkmaar · Amersfoort · Amsterdam · Doetinchem · Ede · Goes · Hoogeveen · Hoorn · Nijmegen · 's-Hertogenbosch · Utrecht
Registry updated 2026-10-15
NCT06274801
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Trial Treatment · Phase 3 · Gossamer Bio USA, Inc.
Amsterdam UMC Stichting, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-10-13
NCT07208331
Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management
Research · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Cardiology Centers of the Netherlands (CCN), Amsterdam
Registry updated 2026-10-09
NCT03683186
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Trial Treatment · Phase 3 · United Therapeutics
VUMC Stichting, Amsterdam
Registry updated 2026-10-06
NCT06059638
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Trial Treatment · Orchestra BioMed, Inc
Amsterdam University Medical Centre, Amsterdam · Maastricht UMC, Maastricht · Isala Klinieken, Zwolle
Registry updated 2026-10-02
NCT06742723
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Trial Treatment · Phase 3 · AstraZeneca
Meander Medisch Centrum, Amersfoort · Amsterdam UMC Stichting, Amsterdam · Albert Schweitzer Ziekenhuis, Dordrecht · Universitair Medisch Centrum Groningen, Groningen · Tergooiziekenhuizen, Hilversum · Leids Universitair Medisch Centrum (LUMC), Leiden · Academisch Ziekenhuis Maastricht, Maastricht · Sint Antonius Ziekenhuis Stichting, Nieuwegein · Isala Klinieken Stichting, Zwolle
Registry updated 2026-09-25
NCT02880631
BAROSTIM THERAPY™ In Resistant Hypertension
Research · CVRx, Inc.
Maastricht University Medical Center, Maastricht
Registry updated 2026-09-11
2025-521143-20-00
Targeting fibrotic tissue with a radioactive-labelled Fibrobody, visible using a full-body PET/CT scan (FibroVision)
Trial Treatment · Phase 1 · Amsterdam UMC Stichting
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-09-10
2024-513613-12-00
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Trial Treatment · Phase 1/2 · Novartis Pharma AG
Amsterdam UMC Stichting, Amsterdam · St. Antonius Ziekenhuis, Nieuwegein
Registry updated 2026-09-04
NCT07365332
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Trial Treatment · Phase 3 · Inhibikase Therapeutics
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-09-02
NCT07773272
Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome
Research · Zuyderland Medisch Centrum
Cardiology, Heerlen
Registry updated 2026-08-19
NCT05027685
The "Global Paradise System" Registry
Research · ReCor Medical, Inc.
Noordwest Ziekenhuisgroep, Alkmaar · Maastricht University Medical Center, Maastricht · Erasmus MC Rotterdam, Rotterdam
Registry updated 2026-06-04
NCT06845345
Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)
Trial Treatment · Phase 4 · Carmen Dietvorst
Sint Franciscus Vlietland Groep Stichting, Rotterdam
Registry updated 2026-04-21
NCT07070583
Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure
Trial Treatment · Rijnstate Hospital
Rijnstate, Arnhem
Registry updated 2026-04-03
NCT06256991
Potassium Correction for RAAS Optimization in Chronic Kidney Disease
Trial Treatment · Phase 4 · University Medical Center Groningen
University Medical Center Groningen, Groningen
Registry updated 2025-12-19
NCT07294794
Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension
Trial Treatment · University of Birmingham
University Medical Centre Utrecht, Utrecht
Registry updated 2025-12-19
NCT04745195
Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium
Research · Maastricht University Medical Center
Maastricht University Medical Center, Maastricht
Registry updated 2025-10-01

All High blood pressure trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error